Guest Editors
Prof. Aldo Alvarez-Risco, Universidad de Lima, Peru
He is an Associate Professor of International Business and coordinator of the Global Logistics and Supply Chain Management Research Group at Universidad de Lima in Perú. He is also PhD at Universidad Autónoma de Nuevo León, Doctor in Pharmacy and Biochemistry, Master in Pharmacology and Pharmacist at the Universidad Nacional Mayor de San Marcos and Master Pharmaceutical Care at Universidad de Granada. He is the coordinator of the South American Network of Pharmaceutical Care (REDSAF). Dr. Alvarez-Risco is the author of various books and articles and has been a speaker at academic events in 22 countries. He has experience as a speaker for radio and TV appearances.
Prof. Jaime A. Yañez, Universidad Norbert Wiener, Peru
Ph.D. in Pharmacology and Toxicology, with a focus in Pharmacokinetics and Pharmacodynamics from Washington State University (WSU), B.Sc. in Food Science and Toxicology with a minor in Chemistry from the University of Idaho (UI). Diplomas in Food Safety and Quality Management, Research Projects, Medicinal Cannabis, and Patents. Currently studying in Harvard University a Program about Clinical Research and Studies. He has more than 20 years of professional experience in the public and private sectors.
Summary
COVID-19
changed people's lives and institutions, creating different impacts such as the
death of family and friends, job losses, business failure, development of
mental illness, limitation of health services, price increases, and various
negative individual and organizational effects.
There
are various reports, but these need to be updated as the situation constantly
changes. The anxiety generated at the pandemic's beginning differs from the
anxiety that may generate the need to be vaccinated. It is also required to
know how depression has evolved in people since this can cause public health
problems on a large scale and at the same time affect families and companies.
Other aspects much less explored are knowing the change that people have had
about their health needs to require telemedicine services. It is also necessary
to know the change in the mental constructs of consumers that may have changed
or extended the purchase intention to various health products.
The
special issue is focused in publish articles describing different approaches
around the impact and expectations of the COVID-19 pandemic. It will be
described outcomes and descriptions in citizens and firms.
Keywords
COVID-19, depression, anxiety, health, telemedicine, telehealth, vaccines, technostress
Published Papers
Login
Register
Submit a Paper
Propose a Special lssue